Mary Shoemaker
Patrimonio netto: - $ in data 31/07/2026
Patrimonio netto: - $ in data 31/07/2026
Mary Teresa Shoemaker currently works at Traws Pharma, Inc., as Independent Director from 2020.
Ms. Shoemaker also formerly worked at Medexus Pharma, Inc., as President, Chief Executive Officer & Director from 2018 to 2020, Pharmion Corp., as Senior Director-Commercial Operations, InterMune, Inc., as Vice President-Sales from 2009 to 2010, and Medexus Pharmaceuticals, Inc., as President-United States Operations.
Ms. Shoemaker received her graduate degree from the University of Central Missouri and undergraduate degree from Missouri State University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
TRAWS PHARMA, INC. -.--% | 09/07/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TRAWS PHARMA, INC. | Direttore/Membro del Consiglio | 01/04/2020 |
| Società | Posizione | Fine |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Corporate Officer/Principal | 22/05/2020 |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for autoimmune diseases | Amministratore Delegato | 01/05/2020 |
| INTERMUNE INC | Vendite & Marketing | 01/07/2010 |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
InterMune, Inc.
InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of products for the treatment of hematology & oncology patients | Health Technology |
Traws Pharma, Inc.
Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
University of Central Missouri
University of Central Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Missouri State University
Missouri State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for autoimmune diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale